Hypervirulent Klebsiella pneumoniae
Payal K Patel1, Thomas A Russo2, Adolf W Karchmer1
1Division of Infectious Diseases, Department of Internal Medicine, Beth Israel Deaconess Medical Center , Harvard Medical School , Boston, Massachusetts.
Open Forum Infectious Diseases
|March 4, 2015
Summary
Hypervirulent Klebsiella pneumoniae causes severe abscesses and metastasis, even in healthy individuals. This case highlights the clinical, genotypic, and phenotypic aspects of this emerging infectious disease.
Area of Science:
- Infectious Diseases
- Microbiology
- Pathogenesis
Background:
- Hypervirulent Klebsiella pneumoniae (hvKP) strains are increasingly recognized for causing severe invasive infections.
- These infections are characterized by abscess formation, particularly in the liver, and distant metastatic spread.
- hvKP infections can occur even in immunocompetent individuals, posing a significant public health challenge.
Purpose of the Study:
- To describe a clinical case of invasive infection caused by a hypervirulent Klebsiella pneumoniae strain.
- To detail the genotypic and phenotypic characteristics of the etiological isolate.
- To provide a brief review of the epidemiology, clinical manifestations, and pathogenesis of hvKP infections.
Main Methods:
- Case report detailing a patient with hvKP infection.
- Genomic and phenotypic analysis of the Klebsiella pneumoniae isolate.
- Literature review on hvKP epidemiology, clinical features, and pathogenesis.
Main Results:
- The case involved a patient with severe abscess formation and metastatic spread attributed to hvKP.
- Genotypic and phenotypic analyses revealed specific virulence factors associated with the isolate.
- Review confirmed the distinct clinical syndrome and pathogenic mechanisms of hvKP.
Conclusions:
- Hypervirulent Klebsiella pneumoniae represents an underappreciated cause of severe invasive disease.
- Understanding the genotypic and phenotypic traits of hvKP is crucial for diagnosis and management.
- Further research into hvKP pathogenesis and epidemiology is warranted to combat this emerging threat.
More Related Videos
Related Concept Videos
Atypical Pneumonia
67
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
Pneumonia II: Pathophysiology
4.4K
The pathophysiology of pneumonia involves the following steps:
4.4K
Pneumonia I: Introduction
1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Clinical Significance of Antibiotic Resistance
60
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
60
Acute Pyelonephritis I: Introduction
1.4K
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.4K


